Lecture 28: Type II-IV Hypersensativities Flashcards
type II (cytotoxic) hypersensitivity occurs through the production of ____or____ that binds to specific allergens located on______
IgM, IgG, cells
2 phases of cytotoxic hypersensitivity
sensitization phase: exposure to antigen leads to IgM or IgG production
Effector phase: re-exposure to antigen allows allergen specific IgM or IgG to bind, causing immune mediated damage or blocks normal function of the cell
antibody dependent cellular cytotoxicity
NK cells or macrophages killing antibody coated target cells
complement mediated lysis
activation of classical complement pathway to form membrane attack complexes to kill target cells
primary immune mediated hemolytic anemia (IMHA) is considered…
idiopathic/autoimmune
secondary IMHA is caused by….
an immunologic response against non-self antigens that have adsorbed or motified normal RBC membranes
- antibodies bind to antigens on RBCs resulting in lysis
- causes include various infectios agents or drugs (antibiotics)
Transfusion reactions are mediated by antibodies that….
bind and lyse transfused RBCs
manifestations result from intravascular hemolysis of transfused RBCs
what can you do to prevent blood transfusion reactions
perform blood typing and cross-matching tests
neonatal isoerythrolysis
hemolytic disease of newborns
- destruction of newborn RBCs, foals and kittens mostly
neonatal isoerythrolysis is mediated by ______that bind and lyse neonatal RBCs
mismatched blood group maternal antibodies
Direct Coomb’s test detects…
antibodies bound to RBCs
agglutintion test
type III (immune complex) hypersensitivity is caused by what
small immune complexes formed by soluble antigens binding to IgG or IgM
two phases of type III immune complex hypersensitivity
Sensitization and effector phases, occur in continuum
sensitization phase of Type III
initial exposure to antigen, results in immune complex formation that deposit into tissues
effector phase of Type III
immune complex activation of complement & recruitment of inflammatory cells to site of deposition
* inflammation results in increased permeability